Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, Pisa University Hospital, and Chair of Cardiology, University of Pisa, Pisa, Italy.
J Cardiovasc Med (Hagerstown). 2024 Oct 1;25(10):749-756. doi: 10.2459/JCM.0000000000001653. Epub 2024 Aug 1.
Lower extremity arterial disease (LEAD) and increased aortic stiffness are associated with higher mortality in patients with chronic coronary syndrome, while their prognostic significance after an acute coronary syndrome (ACS) is less known.
We analyzed prevalence, clinical phenotypes and association of LEAD - assessed by the ankle-brachial index (ABI) - and increased aortic stiffness - assessed by the aortic pulse wave velocity (PWV) - with all-cause mortality and major adverse cardiovascular events (MACE) in patients admitted with an ACS.
Among 270 patients admitted for ACS (mean age 67 years, 80% males), 41 (15%) had an ABI ≤0.9, with 14 of them (34%) presenting with intermittent claudication (symptomatic LEAD). Patients with symptomatic LEAD, compared with those with asymptomatic LEAD or without LEAD, had higher prevalence of cardiovascular risk factors, lower estimated glomerular filtration rate and higher high-sensitivity C-reactive protein. Patients with LEAD, either symptomatic or asymptomatic, more frequently presented with non-ST-elevation myocardial infarction and more frequently had multivessel coronary artery disease. Both symptomatic and asymptomatic LEAD were significantly associated with all-cause mortality after adjustment for confounders, including multivessel disease or carotid artery disease (hazard ratio 4.03, 95% confidence interval 1.61-10.08, P < 0.01), whereas PWV was not associated with the outcome in the univariable model. LEAD and PWV were not associated with a higher risk of MACE (myocardial infarction or unstable angina, stroke, or transient ischemic attack).
LEAD, either clinical or subclinical, but not increased aortic stiffness, is an independent predictor of all-cause mortality in patients admitted for ACS.
下肢动脉疾病(LEAD)和主动脉僵硬度增加与慢性冠状动脉综合征患者的死亡率升高相关,而其在急性冠状动脉综合征(ACS)后的预后意义尚不清楚。
我们分析了通过踝臂指数(ABI)评估的 LEAD 的患病率、临床表型以及与全因死亡率和主要不良心血管事件(MACE)的相关性,以及通过主动脉脉搏波速度(PWV)评估的主动脉僵硬度增加与 ACS 患者的相关性。
在 270 名因 ACS 入院的患者中(平均年龄 67 岁,80%为男性),41 名(15%)ABI ≤0.9,其中 14 名(34%)存在间歇性跛行(有症状的 LEAD)。与无症状 LEAD 或无 LEAD 的患者相比,有症状的 LEAD 患者具有更高的心血管危险因素患病率、更低的估算肾小球滤过率和更高的高敏 C 反应蛋白。有 LEAD 的患者,无论有无症状,更常表现为非 ST 段抬高型心肌梗死,且更常患有多支冠状动脉疾病。在调整混杂因素后,包括多支血管疾病或颈动脉疾病后,有症状和无症状的 LEAD 均与全因死亡率显著相关(危险比 4.03,95%置信区间 1.61-10.08,P <0.01),而在单变量模型中,PWV 与结局无关。LEAD 和 PWV 与 MACE(心肌梗死或不稳定型心绞痛、卒中和短暂性脑缺血发作)风险的增加无关。
在因 ACS 入院的患者中,有症状或无症状的 LEAD 但不是主动脉僵硬度增加是全因死亡率的独立预测因子。